Log In
BCIQ
Print this Print this
 

PEGPH20 (formerly PEGrHuPH20)

  Manage Alerts
Collapse Summary General Information
Company Halozyme Therapeutics Inc.
DescriptionRecombinant human PH20 hyaluronidase enzyme conjugated to polyethylene glycol (PEG)
Molecular Target Hyaluronan
Mechanism of ActionDegrades hyaluronan
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/31/2015

Undisclosed

Undisclosed

Undisclosed

05/27/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today